IPO
-
-
-
-
-
-
-
Lipella Pharmaceuticals (LIPO) delisted from Nasdaq
-
-
-
-
-
-
-
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”
-
-
-
-
-
-
-
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
-
-
-
-
-
-
-
Lipella Pharmaceuticals (LIPO) Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
-
-
-
-
-
-
-
Lipella Pharmaceuticals (LIPO) Launches Innovative Registry to Advance Oral Lichen Planus Research
-
-
-
-
-
-
-
Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Lipella Pharmaceuticals (LIPO) Expands its Advisory Board to Include Oncology Expertise
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

